ZM-H1505R

· Shanghai Zhimeng Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZM-H1505R, covering 2023-05-08 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB [Phase 3]